Notably, we observed activation of the “NRF2-mediated oxidative stress response” in HLRCC versus NS patients as a top altered pathway based on protein-level alterations that was also significantly enriched at the transcript level (Supplemental Table 11). This evidence concerns the gene NFE2L2 and hereditary leiomyomatosis and renal cell cancer.